TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Clinical trials for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Aplastic anemia drug combo study pulled before starting
Disease control TerminatedThis study was designed to test whether combining cyclosporine with drugs that boost platelet production (eltrombopag, hetrombopag, or romiplostim) could help people with newly diagnosed severe aplastic anemia who need blood transfusions. The trial was withdrawn before enrolling …
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Promising combo for aplastic anemia trial pulled before start
Disease control TerminatedThis study was designed to test whether adding enarodustat to cyclosporine helps people with a type of aplastic anemia who need regular blood transfusions. The trial was withdrawn before enrolling any participants, so no results are available. It would have compared the combinati…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC